These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 9662355

  • 1. Alpha synuclein in neurodegenerative disorders: murderer or accomplice?
    Mezey E, Dehejia A, Harta G, Papp MI, Polymeropoulos MH, Brownstein MJ.
    Nat Med; 1998 Jul; 4(7):755-7. PubMed ID: 9662355
    [No Abstract] [Full Text] [Related]

  • 2. Alpha-synuclein and neurodegenerative diseases.
    Goedert M.
    Nat Rev Neurosci; 2001 Jul; 2(7):492-501. PubMed ID: 11433374
    [No Abstract] [Full Text] [Related]

  • 3. Failure of the ubiquitin-proteasome system in Parkinson's disease.
    McNaught KS, Olanow CW, Halliwell B, Isacson O, Jenner P.
    Nat Rev Neurosci; 2001 Aug; 2(8):589-94. PubMed ID: 11484002
    [No Abstract] [Full Text] [Related]

  • 4. Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function.
    Tofaris GK, Razzaq A, Ghetti B, Lilley KS, Spillantini MG.
    J Biol Chem; 2003 Nov 07; 278(45):44405-11. PubMed ID: 12923179
    [Abstract] [Full Text] [Related]

  • 5. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.
    Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M.
    Neurosci Lett; 1998 Jul 31; 251(3):205-8. PubMed ID: 9726379
    [Abstract] [Full Text] [Related]

  • 6. [Recent neuropathology of parkinsonian syndromes].
    Duyckaerts C, Verny M, Hauw JJ.
    Rev Neurol (Paris); 2003 May 31; 159(5 Pt 2):3S11-8. PubMed ID: 12773883
    [Abstract] [Full Text] [Related]

  • 7. Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells.
    Ancolio K, Alves da Costa C, Uéda K, Checler F.
    Neurosci Lett; 2000 May 12; 285(2):79-82. PubMed ID: 10793231
    [Abstract] [Full Text] [Related]

  • 8. Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis.
    Hishikawa N, Niwa J, Doyu M, Ito T, Ishigaki S, Hashizume Y, Sobue G.
    Am J Pathol; 2003 Aug 12; 163(2):609-19. PubMed ID: 12875980
    [Abstract] [Full Text] [Related]

  • 9. Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein.
    Arawaka S, Saito Y, Murayama S, Mori H.
    Neurology; 1998 Sep 12; 51(3):887-9. PubMed ID: 9748051
    [Abstract] [Full Text] [Related]

  • 10. Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells.
    Rideout HJ, Larsen KE, Sulzer D, Stefanis L.
    J Neurochem; 2001 Aug 12; 78(4):899-908. PubMed ID: 11520910
    [Abstract] [Full Text] [Related]

  • 11. Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons.
    McLean PJ, Kawamata H, Hyman BT.
    Neuroscience; 2001 Aug 12; 104(3):901-12. PubMed ID: 11440819
    [Abstract] [Full Text] [Related]

  • 12. [Pathology of neuronal and glial alpha-synucleinopathies].
    Wakabayashi K.
    No To Shinkei; 2005 Aug 12; 57(8):667-82. PubMed ID: 16146211
    [No Abstract] [Full Text] [Related]

  • 13. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC, Scott GB, Rose SA, Tan NG, Robinson PA.
    J Neurochem; 2004 Jul 12; 90(2):379-91. PubMed ID: 15228595
    [Abstract] [Full Text] [Related]

  • 14. Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies.
    Trimmer PA, Borland MK, Keeney PM, Bennett JP, Parker WD.
    J Neurochem; 2004 Feb 12; 88(4):800-12. PubMed ID: 14756800
    [Abstract] [Full Text] [Related]

  • 15. Alpha-synuclein: normal function and role in neurodegenerative diseases.
    Norris EH, Giasson BI, Lee VM.
    Curr Top Dev Biol; 2004 Feb 12; 60():17-54. PubMed ID: 15094295
    [Abstract] [Full Text] [Related]

  • 16. alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome.
    Tofaris GK, Layfield R, Spillantini MG.
    FEBS Lett; 2001 Nov 30; 509(1):22-6. PubMed ID: 11734199
    [Abstract] [Full Text] [Related]

  • 17. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy.
    Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H.
    Neurosci Lett; 1998 Jun 19; 249(2-3):180-2. PubMed ID: 9682846
    [Abstract] [Full Text] [Related]

  • 18. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.
    Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM.
    Science; 2000 Nov 03; 290(5493):985-9. PubMed ID: 11062131
    [Abstract] [Full Text] [Related]

  • 19. alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy.
    Sone M, Yoshida M, Hashizume Y, Hishikawa N, Sobue G.
    Acta Neuropathol; 2005 Jul 03; 110(1):19-26. PubMed ID: 15895299
    [Abstract] [Full Text] [Related]

  • 20. Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy.
    Shoji M, Harigaya Y, Sasaki A, Uéda K, Ishiguro K, Matsubara E, Watanabe M, Ikeda M, Kanai M, Tomidokoro Y, Shizuka M, Amari M, Kosaka K, Nakazato Y, Okamoto K, Hirai S.
    J Neurol Neurosurg Psychiatry; 2000 May 03; 68(5):605-8. PubMed ID: 10766891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.